Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 9 | Showing Results 1 - 5 of 42

RNS System Post-Approval Study in Epilepsy

The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data...

Ryder Gwinn, M.D.
  • Swedish Medical Center

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy

Key Inclusion Criteria:-Diagnosis of focal epilepsy per 1989 International League Against Epilepsy (ILAE) criteria at least 3 years before study...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

HVP AMPLATZER™ PFO Occluder Post Approval Study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval...

Ethan Korngold MD
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • TOC Gateway - Heart Clinic

Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis

This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age.-Patients with...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial

FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the...

Elisabeth Lucassen, M.D.
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 9 | Showing Results 1 - 5 of 42